KRISTEN LOCKE: Open Payments
NPI 1649779760 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 94 payments from 13 companies in 2025. Trend: 2023 $2,462 · 2024 $1,646 · 2025 $1,840
Food & beverage: $1,840
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $394 |
| Alkermes, Inc. | 8 | $344 |
| ABBVIE INC. | 21 | $232 |
| Collegium Pharmaceutical, Inc. | 15 | $208 |
| Neurocrine BioSciences, Inc. | 12 | $198 |
| Supernus Pharmaceuticals, Inc. | 6 | $111 |
| Axsome Therapeutics, Inc. | 4 | $102 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
Products named: CAPLYTA, LYBALVI, VRAYLAR, Jornay PM, INGREZZA, Qelbree, ARISTADA, Auvelity.
Industry payments across TN — which companies pay providers there.
